JPM JPMORGAN CHASE & CO

Price Chart

Executive Summary

Oppenheimer downgraded JPMorgan Chase & Co. to Perform from Outperform on November 20, 2024, as part of a five-firm cluster action on the stock. The firm has an 83% accuracy rate on 6 calls and an average return of 14.2%, placing it among top-tier analysts covering JPM. Consensus remains heavily bullish with 18 Buy ratings (3 strong, 15 buy) versus 13 Hold and 0 Sell, though the mean price target of $342.19 implies only 14.3% upside from the current $299.31. The price target range spans $295 to $391, with Oppenheimer's lack of a new PT leaving ambiguity. Analyst momentum is flat with zero upgrades or downgrades in the past 30 days, but EPS revisions for the current fiscal year show 11 upward revisions versus 0 downward, signaling underlying earnings strength. Insider selling is notable — five executives sold over $8 million in May 2026, including CEO-level figures, which diverges from the bullish consensus. Congressional activity is mixed with two buys and two sells. The bottom line: Oppenheimer's downgrade is a contrarian call from a high-accuracy firm, but the lack of a price target and the bullish consensus limit its standalone impact; traders should watch for further downgrade catalysts before acting.

Impact Score

Consensus & Targets

Consensus is heavily bullish: 3 strong buy, 15 buy, 13 hold, 0 sell, 0 strong sell (31 analysts total). The overwhelming majority of analysts rate JPM as a Buy, making Oppenheimer's downgrade a contrarian move against the consensus direction.

Current price is $299.31. Mean target is $342.19, median $340, high $391, low $295. Implied upside to mean is 14.3%. Oppenheimer did not provide a price target, so its view sits outside the consensus range, but the low target of $295 suggests some analysts see downside risk.

Recent Analyst Activity

Analyst activity in the past 30 days shows 0 upgrades and 0 downgrades, indicating a quiet period. EPS revisions are positive: for the current fiscal year, 11 revisions up and 0 down over 30 days; for next year, 11 up and 0 down. This earnings momentum supports the bullish consensus and contrasts with Oppenheimer's downgrade.

Firm Track Record — Oppenheimer

Oppenheimer accuracy: 52% on 1809 calls | avg return: 3.6%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.

Oppenheimer has an 83% accuracy rate on 6 calls with an average return of 14.2%, ranking as a top-tier firm. Among all firms covering JPM, the best performers include Wells Fargo (100% on 6 calls, avg return 7%), Baird (100% on 2 calls, avg 9.3%), and RBC Capital (100% on 3 calls, avg 10.3%). The worst is Jefferies (50% on 2 calls, avg 1.4%). Oppenheimer's downgrade carries more weight given its strong track record.

Earnings Estimates

Next earnings: Jul 14, 2026

Cross-Platform Signals

Insider trades show significant selling: five executives sold over $8 million in May 2026, including Mary Erdoes ($1.98M) and Stacey Friedman ($1.64M). This aligns with the bearish downgrade but is a weak signal per academic literature. Congressional activity is mixed: two buys (Keating, Khanna) and two sells (Whitehouse, Fletcher). Institutional changes show Norges Bank exiting a position and Two Sigma trimming by 46.4%, while Dodge & Cox trimmed by 27-36%. Short interest is 56.8% of float, suggesting elevated bearish positioning. The insider selling and institutional trims converge with the downgrade, but the strong EPS revisions diverge.

Documents Analyzed

Report based on filing metadata.

US Market Status